Optometrist

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY…

1 year ago

Association for Pediatric Vision Announces a Free Vision Screening Training Offered Nationwide

TAMPA, FL / ACCESSWIRE / August 21, 2023 / The Association for Pediatric Vision, a program of Lions World Vision…

1 year ago

Virginia’s Largest Ophthalmology, Optometry Clinic, and Storefront Transitions to eClinicalWorks Vision Solutions

50+ provider Virginia Eye Institute deploys eClinicalWorks EHR and healow patient engagement solutionsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,…

1 year ago

RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy

Technology Enables Physicians to Remotely Make Pre-Diagnostic Assessment Regarding Whether an In-Person Diagnostic Examination of Ocular Anatomy is WarrantedPETALUMA, Calif.,…

1 year ago

Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million

Press ReleaseNicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 millionNCX 470 therapeutic profile positively received…

1 year ago

Ocuphire Announces FDA Acceptance of New Drug Application and PDUFA Date of September 28, 2023 for Nyxol® Eye Drops for Reversal of Mydriasis

If Approved Later This Year, Nyxol Could be the Only Commercially Available Eye Drop for Reversal of DilationFARMINGTON HILLS, Mich.,…

2 years ago

Eye On Health Phoenix Offers New Expert Diabetic Eye Care Exams In Phoenix, Arizona

Phoenix, Arizona, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Eye on Health Phoenix was founded in 2013 by Dr. Balocca, an…

2 years ago

NEXGEL Develops New Hydrogel Patch to Treat Amblyopia

Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion…

2 years ago

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an…

2 years ago

Newly Launched Digital Platform for Optometrists Allows Patients to Safely Interact with Doctors

Opti-Xpres Offers Contactless Patient Scheduling, Paperwork, Payment Processing, and a Virtual Glasses Try-On Feature  PHOENIX – In an effort to…

4 years ago